Go to deals
Healthcare

IXICO plc has completed a placing, subscription and retail offer

October 2024 — IXICO plc has raised US$5 million (£4.05 million) through an over-subscribed placing, subscription and retail offer, issuing 42,621,508 new ordinary shares at 9.5 pence per share, a premium to the price at the time. This important fundraising initiative enables the company to further its pioneering work in neuroscience through advanced imaging and data analytics.

IXICO is a leading medical imaging services provider, specializing in supporting clinical trials for pharmaceutical and biotech companies. With a global network of imaging sites and its custom TrialTracker platform, IXICO offers advanced imaging analytics and digital biomarker services for a variety of neurological diseases, including Alzheimer’s, Huntington’s, Parkinson’s and rare neurological disorders. The company is committed to regulatory compliance and has extensive experience in early-phase clinical development and extended longitudinal studies.

Our role in the transaction

Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised IXICO plc on this transaction.

Talk to the deal team

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Life & Mobility has attracted investor Bolster Investment Partners
Private Equity | Healthcare

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Learn more
7BidCo has completed the sell-out procedure for the shares of STAR7
Private Equity | Other Industries

7BidCo has completed the sell-out procedure for the shares of STAR7

7BidCo S.p.A. has completed the sell-out procedure for 8.5% of STAR7 S.p.A.’s shares.

Learn more
Bischoff & Bischoff has acquired Trendmobil
Private Equity | Healthcare

Bischoff & Bischoff has acquired Trendmobil

Bischoff & Bischoff Medizin- und Rehabilitationstechnik GmbH, a portfolio company of Lafayette Mittelstand Capital, has acquired Trendmobil GmbH as a strategic add-on. 

Learn more